Advertisement
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

0
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
As a result of the increasing popularity of high-deductible health care plans

Expansion of High-Deductible Plans to Impact Physician Care

0
Physicians must be able to balance provision of good clinical care with ability to limit costs
A new diagnostic to differentiate between HIV-1 antibodies

FDA Approves Test to Differentiate HIV Viruses

0
Among people two years and older
Combination treatments show promise for HIV and hepatitis C virus coinfection

Combo Treatments Promising for HIV-HCV Coinfection

0
Sustained virologic response for ledipasvir and sofosbuvir; and for daclatasvir and sofosbuvir
Early initiation of antiretroviral therapy is associated with improved outcomes in HIV

More Evidence of Benefits for Early Initiation of ART

0
Two studies show benefits in patients with asymptomatic HIV and in African patients
A French teen born with HIV has the disease under control even though she stopped treatment 12 years ago

Teen’s HIV Under Control 12 Years After Stopping Drug Tx

0
Girl is in remission of infection but she is still infected, not cured
A proposed rule from the Centers for Medicare & Medicaid Services would implement physicians' calls to pay for end-of-life counseling

CMS May Adopt Doctors’ Calls for End-of-Life Counseling

0
Two new codes would be established; would be used for conversations about care options
Clinicians may be biased when it comes to the sexual orientation of patients

Clinicians May Harbor Biases About Sexual Orientation

0
Findings show need for sensitivity training, expert suggests
Strategies should be adopted to help with implementation of the Choosing Wisely program

Choosing Wisely: How to Implement in Clinical Practice

0
Strategies to improve chance of success include familiarization with evidence behind recs
An individual's genetic makeup may determine whether an HIV vaccine will work

Genes May Be Key to a Better HIV Vaccine

0
Findings challenge one-shot-fits-all approach, could guide development of future vaccines